Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
CeGaT GmbH Germany | 1 | 1 |
|
Aicardi-Goutieres syndrome type 2 Bioarray Spain | 1 | 1 |
|
Leukodystrophy / Leukencephalopathy and differential diagnoses Panel CeGaT GmbH Germany | 68 | 175 |
|
Basal ganglia calcification Panel CeGaT GmbH Germany | 52 | 27 |
|
Leukodystrophy and Leukoencephalopathy Panel CeGaT GmbH Germany | 36 | 35 |
|
Leukodystrophy / Leukencephalopathy Panel CeGaT GmbH Germany | 36 | 35 |
|
Aicardi-Goutières Syndrome Panel CeGaT GmbH Germany | 10 | 10 |
|
Epileptic Encephalopathy Panel CeGaT GmbH Germany | 25 | 77 |
|
MGZ Medical Genetics Center Germany | 1 | 6 |
|
Brain Malformations / Neuronal Migration Disorders MGZ Medical Genetics Center Germany | 2 | 266 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 155 | 69 |
|
Epileptic syndromes with epilepsy and intellectual disability panel Genome Diagnostics Laboratory University Medical Center Utrecht Netherlands | 74 | 50 |
|
Aicardi-Goutieres Syndrome NGS Panel Fulgent Genetics United States | 9 | 5 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.